More than a year after its promised deadline to investors, drugmaker puts alarming results in federal government's "virtual ...

Pfizer’s mRNA flu vaccine outperformed the standard flu shot in a Phase 3 clinical trial, according to results published ...

In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has ...

NEW YORK, N.Y. – Pfizer Inc. on Monday released detailed analyses of myocarditis cases linked to its COVID-19 vaccine, ...

In a large-scale trial, modRNA was significantly better at preventing confirmed flu cases than a typical seasonal flu shot.

Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. | Pfizer has ...

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported.

Pfizer Canada says it has placed temporary limits on orders of one of its COVID shots at community pharmacies, found outside ...

Shares of several major vaccine makers lost ground Monday following a report U.S. vaccine approval rules could become ...

A top FDA official has proposed broad changes to the review and approval process for vaccines, citing a new internal review linking the deaths of 10 children to COVID-19 vaccines. In an internal memo ...

In the wake of the memo, several vaccine experts responded that the CBER director's claim about the deaths requires more ...